Atlantic Union Bankshares’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.14M Sell
27,090
-1,153
-4% -$177K 0.08% 206
2025
Q4
$3.89M Sell
28,243
-870
-3% -$114K 0.07% 216
2025
Q3
$3.73M Buy
29,113
+556
+2% +$67.8K 0.07% 229
2025
Q2
$3.46M Buy
28,557
+10,969
+62% +$1.24M 0.08% 213
2025
Q1
$1.96M Buy
17,588
+85
+0.5% +$9.05K 0.12% 141
2024
Q4
$1.7M Sell
17,503
-208
-1% -$22.2K 0.1% 156
2024
Q3
$2.04M Sell
17,711
-170
-1% -$19.3K 0.12% 152
2024
Q2
$1.9M Sell
17,881
-136
-0.8% -$13.7K 0.12% 152
2024
Q1
$1.74M Sell
18,017
-1,349
-7% -$138K 0.15% 132
2023
Q4
$1.96M Sell
19,366
-2,131
-10% -$206K 0.18% 121
2023
Q3
$2.19M Sell
21,497
-1,214
-5% -$123K 0.22% 98
2023
Q2
$2.29M Sell
22,711
-804
-3% -$80.4K 0.23% 95
2023
Q1
$2.16M Sell
23,515
-1,317
-5% -$115K 0.23% 102
2022
Q4
$2.25M Sell
24,832
-669
-3% -$56.3K 0.24% 103
2022
Q3
$1.94M Sell
25,501
-3,027
-11% -$251K 0.22% 100
2022
Q2
$2.41M Sell
28,528
-1,383
-5% -$121K 0.25% 93
2022
Q1
$2.63M Sell
29,911
-4,380
-13% -$379K 0.23% 99
2021
Q4
$3M Sell
34,291
-15,579
-31% -$1.29M 0.25% 92
2021
Q3
$4.08M Sell
49,870
-10,303
-17% -$927K 0.38% 71
2021
Q2
$5.49M Sell
60,173
-9,927
-14% -$884K 0.53% 56
2021
Q1
$5.99M Buy
70,100
+773
+1% +$69.4K 0.61% 54
2020
Q4
$6.55M Buy
69,327
+662
+1% +$57.8K 0.68% 50
2020
Q3
$5.97M Buy
68,665
+27
+0% +$2.34K 0.7% 44
2020
Q2
$6M Buy
68,638
+1,779
+3% +$154K 0.75% 37
2020
Q1
$5.51M Sell
66,859
-2,350
-3% -$210K 0.8% 34
2019
Q4
$6.55M Buy
69,209
+315
+0.5% +$28.3K 0.84% 29
2019
Q3
$5.99M Sell
68,894
-135
-0.2% -$12.1K 0.8% 32
2019
Q2
$6.3M Buy
69,029
+29,922
+77% +$2.53M 0.85% 30
2019
Q1
$3.37M Sell
39,107
-3,689
-9% -$296K 0.93% 40
2018
Q4
$3.29M Sell
42,796
-501
-1% -$39K 1.07% 38
2018
Q3
$3.34M Sell
43,297
-60
-0.1% -$4.44K 1.01% 46
2018
Q2
$2.94M Sell
43,357
-466
-1% -$32.2K 0.95% 46
2018
Q1
$3.17M Buy
43,823
+1,851
+4% +$141K 0.98% 48
2017
Q4
$3.16M Buy
41,972
+388
+0.9% +$29.3K 0.98% 45
2017
Q3
$3.2M Sell
41,584
-289
-0.7% -$21.8K 1.08% 45
2017
Q2
$3.13K Buy
41,873
+110
+0.3% +$7.8K 1.08% 47
2017
Q1
$2.78K Buy
41,763
+2,989
+8% +$199K 0.99% 50
2016
Q4
$2.53M Buy
38,774
+1,134
+3% +$73.6K 0.94% 50
2016
Q3
$2.66M Buy
37,640
+1,266
+3% +$92.3K 1.02% 46
2016
Q2
$2.69M Buy
36,374
+3,316
+10% +$229K 1.04% 45
2016
Q1
$2.15M Buy
33,058
+3,952
+14% +$269K 0.89% 51
2015
Q4
$2.24M Buy
29,106
+3,697
+15% +$294K 0.98% 46
2015
Q3
$2.09M Buy
25,409
+3,580
+16% +$319K 0.97% 45
2015
Q2
$1.92M Sell
21,829
-1,302
-6% -$119K 0.91% 49
2015
Q1
$2.04M Sell
23,131
-2,548
-10% -$226K 0.94% 48
2014
Q4
$2.13M Sell
25,679
-1,111
-4% -$92.1K 0.95% 49
2014
Q3
$2.26M Sell
26,790
-361
-1% -$29.2K 1.06% 33
2014
Q2
$2.2M Sell
27,151
-7,528
-22% -$592K 1.03% 37
2014
Q1
$2.38M Buy
+34,679
New +$2.53M 1.09% 35

Other funds holding NVS

Atlantic Union Bankshares's NVS Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its Novartis (NVS) stake by 4.1% in Q1 2026, selling an estimated $177K and leaving 27,090 shares worth $4.14M. The position accounts for 0.08% of the portfolio, ranked #206.

Atlantic Union Bankshares first reported a position in NVS in Q1 2014 and has held it in 49 quarters since. The position peaked at $6.55M in Q4 2019. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Atlantic Union Bankshares held 27,090 shares of Novartis worth $4.14M as of Q1 2026.
  • Atlantic Union Bankshares sold 1,153 Novartis shares in Q1 2026, an estimated $177K.
  • Novartis made up 0.08% of Atlantic Union Bankshares's portfolio in Q1 2026, its #206 holding.
  • Atlantic Union Bankshares first reported a position in Novartis in Q1 2014 and has held it in 49 quarters since.
  • Atlantic Union Bankshares's Novartis position peaked at $6.55M in Q4 2019.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.